ARTICLE | Clinical News
ViroLogic pops on PhenoSense data
July 5, 2001 7:00 AM UTC
VLGC was up $0.90 (33%) to $3.65 on Thursday on news that in a retrospective analysis of blood samples from 30 treatment-experienced patients, its PhenoSense HIV drug resistance assay identified patie...